speb/financial-data huggingface dataset:
DMII balance_sheet (annual, 2025-12-31) — Current Liabilities: 300864.00
DMII balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 300864.00
DMII income_statement (annual, 2025-12-31) — Diluted Average Shares: 27714452.00
DMII income_statement (annual, 2025-12-31) — Diluted EPS: 0.15
DMII income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 4187050.00
DMII income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 4330608.00
DMII balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 0.00
DMII balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 0.00
DMII income_statement (annual, 2025-12-31) — EBIT: -1300498.00
DMII income_statement (quarterly, 2025-12-31) — EBIT: -1047585.00
DMII income_statement (annual, 2025-12-31) — EBITDA: -1300498.00
DMII income_statement (quarterly, 2025-12-31) — EBITDA: -1047585.00
DMII cash_flow (annual, 2025-12-31) — End Cash Position: 223.00
DMII cash_flow (quarterly, 2025-12-31) — End Cash Position: 223.00
DMII cash_flow (annual, 2025-12-31) — Financing Cash Flow: 501001419.00
DMII cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 0.00
DMII cash_flow (annual, 2025-12-31) — Free Cash Flow: -1018231.00
DMII cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -314864.00
DMII income_statement (annual, 2025-12-31) — General And Administrative Expense: 488385.00
DMII income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 235472.00
DMII income_statement (annual, 2025-12-31) — Interest Income: 4933800.00
DMII income_statement (quarterly, 2025-12-31) — Interest Income: 4824445.00
DMII income_statement (annual, 2025-12-31) — Interest Income Non Operating: 4933800.00
DMII income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 4824445.00
DMII balance_sheet (annual, 2025-12-31) — Invested Capital: 487158973.00
DMII balance_sheet (quarterly, 2025-12-31) — Invested Capital: 487158973.00
DMII cash_flow (annual, 2025-12-31) — Investing Cash Flow: -500000000.00
DMII cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 0.00
DMII cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 502000000.00
DMII cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
DMII cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
DMII cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
DMII cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 502000000.00
DMII cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
DMII income_statement (annual, 2025-12-31) — Net Income: 4187050.00
DMII income_statement (quarterly, 2025-12-31) — Net Income: 4330608.00
DMII income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 4187050.00
DMII income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 4330608.00
DMII income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 4187050.00
DMII income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 4330608.00
DMII income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 4187050.00
DMII income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 4330608.00
DMII income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 4187050.00
DMII income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 4330608.00
DMII cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 4187050.00
DMII cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 4330608.00
DMII income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 4187050.00
DMII income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 4330608.00
DMII income_statement (annual, 2025-12-31) — Net Interest Income: 4933800.00
DMII income_statement (quarterly, 2025-12-31) — Net Interest Income: 4824445.00
DMII cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -500000000.00
DMII cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
DMII cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -533781.00
DMII cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
DMII income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 4933800.00
DMII income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 4824445.00
DMII cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -464800.00
DMII cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
DMII cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -533781.00
DMII cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 0.00
DMII balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 487158973.00
DMII balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 487158973.00
DMII balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 0.00
DMII balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 0.00
DMII income_statement (annual, 2025-12-31) — Normalized EBITDA: -1854246.00
DMII income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -1047585.00
DMII income_statement (annual, 2025-12-31) — Normalized Income: 3749589.08
DMII income_statement (quarterly, 2025-12-31) — Normalized Income: 4330608.00
DMII cash_flow (annual, 2025-12-31) — Operating Cash Flow: -1018231.00
DMII cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -314864.00
DMII cash_flow (annual, 2025-12-31) — Operating Gains Losses: -553748.00
DMII income_statement (annual, 2025-12-31) — Operating Income: -1300498.00
DMII income_statement (quarterly, 2025-12-31) — Operating Income: -1047585.00
DMII income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
DMII income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
DMII balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 63700000.00
DMII balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 63700000.00
DMII income_statement (annual, 2025-12-31) — Other Gand A: 488385.00
DMII income_statement (quarterly, 2025-12-31) — Other Gand A: 235472.00
DMII income_statement (annual, 2025-12-31) — Other Income Expense: 553748.00
DMII cash_flow (annual, 2025-12-31) — Other Non Cash Items: -4856001.00
DMII cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -4824446.00
DMII balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 504933800.00
DMII balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 504933800.00
DMII income_statement (annual, 2025-12-31) — Other Special Charges: -553748.00
DMII balance_sheet (annual, 2025-12-31) — Payables: 99359.00
DMII balance_sheet (quarterly, 2025-12-31) — Payables: 99359.00
DMII balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 300864.00
DMII balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 300864.00
DMII balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
DMII balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
DMII balance_sheet (annual, 2025-12-31) — Prepaid Assets: 25814.00
DMII balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 25814.00
DMII income_statement (annual, 2025-12-31) — Pretax Income: 4187050.00
DMII income_statement (quarterly, 2025-12-31) — Pretax Income: 4330608.00
DMII income_statement (annual, 2025-12-31) — Provision For Doubtful Accounts: 812113.00
DMII cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 812113.00
DMII cash_flow (annual, 2025-12-31) — Purchase Of Investment: -500000000.00
DMII cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
DMII balance_sheet (annual, 2025-12-31) — Receivables: 0.00
DMII balance_sheet (quarterly, 2025-12-31) — Receivables: 0.00
DMII cash_flow (annual, 2025-12-31) — Repayment Of Debt: -533781.00
DMII cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
DMII balance_sheet (annual, 2025-12-31) — Retained Earnings: -17776196.00
DMII balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -17776196.00
DMII income_statement (annual, 2025-12-31) — Selling General And Administration: 488385.00
DMII income_statement (quarterly, 2025-12-31) — Selling General And Administration: 235472.00
DMII balance_sheet (annual, 2025-12-31) — Share Issued: 63700000.00
DMII balance_sheet (quarterly, 2025-12-31) — Share Issued: 63700000.00
DMII cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 0.00
DMII cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 0.00
DMII cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -533781.00
DMII cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: 0.00
DMII income_statement (annual, 2025-12-31) — Special Income Charges: 553748.00
DMII balance_sheet (annual, 2025-12-31) — Stockholders Equity: 487158973.00
DMII balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 487158973.00
DMII balance_sheet (annual, 2025-12-31) — Tangible Book Value: 487158973.00
DMII balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 487158973.00
DMII income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 116287.08
DMII income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
DMII income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
DMII income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
DMII balance_sheet (annual, 2025-12-31) — Total Assets: 504959837.00
DMII balance_sheet (quarterly, 2025-12-31) — Total Assets: 504959837.00
DMII balance_sheet (annual, 2025-12-31) — Total Capitalization: 487158973.00
DMII balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 487158973.00
DMII balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 487158973.00
DMII balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 487158973.00
DMII income_statement (annual, 2025-12-31) — Total Expenses: 1300498.00
DMII income_statement (quarterly, 2025-12-31) — Total Expenses: 1047585.00
DMII balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 17800864.00
DMII balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 17800864.00
DMII balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 504933800.00
DMII balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 504933800.00
DMII balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 17500000.00
DMII balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 17500000.00
DMII income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -488385.00
DMII income_statement (annual, 2025-12-31) — Total Unusual Items: 553748.00
DMII income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 553748.00
DMII balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 17500000.00
DMII balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 17500000.00
DMII balance_sheet (annual, 2025-12-31) — Working Capital: -274827.00
DMII balance_sheet (quarterly, 2025-12-31) — Working Capital: -274827.00
DMII income_statement (quarterly, 2026-03-31) — +Operating Expense: 102030.00
DMII income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
DMII balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 49166.00
DMII balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 0.00
DMII income_statement (quarterly, 2026-03-31) — Basic Average Shares: 63700000.00
DMII income_statement (quarterly, 2026-03-31) — Basic EPS: 0.07
DMII cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 223.00
DMII balance_sheet (quarterly, 2026-03-31) — Capital Stock: 509375019.00
DMII balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 347720.00
DMII balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 347720.00
DMII balance_sheet (quarterly, 2026-03-31) — Cash Financial: 347720.00
DMII cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 450000.00
DMII cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -102503.00
DMII cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -22246.00
DMII cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -22246.00
DMII cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 21773.00
DMII cash_flow (quarterly, 2026-03-31) — Change In Receivables: 30000.00
DMII cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 29527.00
DMII cash_flow (quarterly, 2026-03-31) — Changes In Cash: 347497.00
DMII balance_sheet (quarterly, 2026-03-31) — Common Stock: 509375019.00
DMII balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 491559126.00
DMII balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 167119.00
DMII balance_sheet (quarterly, 2026-03-31) — Current Assets: 351761.00
DMII balance_sheet (quarterly, 2026-03-31) — Current Debt: 450000.00
DMII balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 450000.00
DMII balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 666285.00
DMII income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 63700000.00
DMII income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.07
DMII income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 4337820.00
DMII balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 0.00
DMII income_statement (quarterly, 2026-03-31) — EBIT: -102030.00
DMII income_statement (quarterly, 2026-03-31) — EBITDA: -102030.00
DMII cash_flow (quarterly, 2026-03-31) — End Cash Position: 347720.00
DMII cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 450000.00
DMII cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -102503.00
DMII income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 132030.00
DMII income_statement (quarterly, 2026-03-31) — Interest Income: 4439850.00
DMII income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 4439850.00
DMII balance_sheet (quarterly, 2026-03-31) — Invested Capital: 492009126.00
DMII cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 450000.00
DMII balance_sheet (quarterly, 2026-03-31) — Net Debt: 102280.00
DMII income_statement (quarterly, 2026-03-31) — Net Income: 4337820.00
DMII income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 4337820.00
DMII income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 4337820.00
DMII income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 4337820.00
DMII income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 4337820.00
DMII cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 4337820.00
DMII income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 4337820.00
DMII income_statement (quarterly, 2026-03-31) — Net Interest Income: 4439850.00
DMII cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 450000.00
DMII income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 4439850.00
DMII cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 450000.00
DMII balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 491559126.00
DMII income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -102030.00
DMII income_statement (quarterly, 2026-03-31) — Normalized Income: 4337820.00
DMII cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -102503.00
DMII income_statement (quarterly, 2026-03-31) — Operating Income: -102030.00
DMII income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
DMII balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 63700000.00
DMII balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 450000.00
DMII income_statement (quarterly, 2026-03-31) — Other Gand A: 132030.00
DMII cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -4439850.00
DMII balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 509373650.00
DMII balance_sheet (quarterly, 2026-03-31) — Payables: 49166.00
DMII balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 216285.00
DMII balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
DMII balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 4041.00
DMII income_statement (quarterly, 2026-03-31) — Pretax Income: 4337820.00
DMII income_statement (quarterly, 2026-03-31) — Provision For Doubtful Accounts: -30000.00
DMII cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: -30000.00
DMII balance_sheet (quarterly, 2026-03-31) — Receivables: 0.00
DMII balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -17815893.00
DMII income_statement (quarterly, 2026-03-31) — Selling General And Administration: 132030.00
DMII balance_sheet (quarterly, 2026-03-31) — Share Issued: 63700000.00
DMII cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 450000.00
DMII balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 491559126.00
DMII balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 491559126.00
DMII income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
DMII income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
DMII balance_sheet (quarterly, 2026-03-31) — Total Assets: 509725411.00
DMII balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 491559126.00
DMII balance_sheet (quarterly, 2026-03-31) — Total Debt: 450000.00
DMII balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 491559126.00
DMII income_statement (quarterly, 2026-03-31) — Total Expenses: 102030.00
DMII balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 18166285.00
DMII balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 509373650.00
DMII balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 17500000.00
DMII income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -132030.00
DMII balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 17500000.00
DMII balance_sheet (quarterly, 2026-03-31) — Working Capital: -314524.00
DML.TO income_statement (annual, 2021-12-31) — Cost Of Revenue: 12621000.00
DML.TO cash_flow (annual, 2021-12-31) — Depletion: 7385000.00
DML.TO balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 20337000.00
DML.TO balance_sheet (annual, 2021-12-31) — Duefrom Related Parties Current: 533000.00
DML.TO balance_sheet (annual, 2021-12-31) — Employee Benefits: 1154000.00
DML.TO balance_sheet (annual, 2021-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 141000.00
DML.TO balance_sheet (annual, 2021-12-31) — Finished Goods: 451000.00
DML.TO cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: 6746000.00
DML.TO income_statement (annual, 2021-12-31) — Gross Profit: 7379000.00
DML.TO cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 0.00
DML.TO cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -252000.00
DML.TO balance_sheet (annual, 2021-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1154000.00
DML.TO balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 221000.00
DML.TO balance_sheet (annual, 2021-12-31) — Other Receivables: 2000.00
DML.TO cash_flow (annual, 2021-12-31) — Pension And Employee Benefit Expense: -110000.00
DML.TO balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 120000.00
DML.TO balance_sheet (annual, 2021-12-31) — Prepaid Assets: 1310000.00
DML.TO income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 12621000.00
DML.TO income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 0.00
DML.TO balance_sheet (annual, 2021-12-31) — Taxes Receivable: 255000.00
DML.TO income_statement (annual, 2022-12-31) — +Operating Expense: 40333000.00
DML.TO income_statement (annual, 2022-12-31) — +Total Revenue: 8973000.00
DML.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 5434000.00
DML.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 3184000.00
DML.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -35545000.00
DML.TO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 70281000.00
DML.TO balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 87000.00
DML.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 818891000.00
DML.TO income_statement (annual, 2022-12-31) — Basic EPS: 0.02
DML.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 63998000.00
DML.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -6869000.00
DML.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 1539209000.00
DML.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 50915000.00
DML.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 58937000.00
DML.TO balance_sheet (annual, 2022-12-31) — Cash Equivalents: 47851000.00
DML.TO balance_sheet (annual, 2022-12-31) — Cash Financial: 3064000.00
DML.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 20959000.00
DML.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -6761000.00
DML.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -28144000.00
DML.TO cash_flow (annual, 2022-12-31) — Change In Inventory: 741000.00
DML.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1385000.00
DML.TO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 129000.00
DML.TO cash_flow (annual, 2022-12-31) — Change In Receivables: -512000.00
DML.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: 1743000.00
DML.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -13946000.00
DML.TO balance_sheet (annual, 2022-12-31) — Common Stock: 1539209000.00
DML.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 436016000.00
DML.TO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 19551000.00
DML.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 5153000.00
DML.TO balance_sheet (annual, 2022-12-31) — Current Assets: 67160000.00
DML.TO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 4915000.00
DML.TO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 4915000.00
DML.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 18415000.00
DML.TO balance_sheet (annual, 2022-12-31) — Current Provisions: 2865000.00
DML.TO cash_flow (annual, 2022-12-31) — Deferred Income Tax: -2269000.00
DML.TO cash_flow (annual, 2022-12-31) — Deferred Tax: -2269000.00
DML.TO cash_flow (annual, 2022-12-31) — Depletion: 8667000.00
DML.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 8667000.00
DML.TO balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
DML.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 828735000.00
DML.TO income_statement (annual, 2022-12-31) — Diluted EPS: 0.02
DML.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 14354000.00
DML.TO balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 508000.00
DML.TO balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 4036000.00
DML.TO income_statement (annual, 2022-12-31) — EBIT: 10363000.00
DML.TO income_statement (annual, 2022-12-31) — EBITDA: 19030000.00
DML.TO income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -2887000.00
DML.TO cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 2887000.00
DML.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 863000.00
DML.TO balance_sheet (annual, 2022-12-31) — Employee Benefits: 1081000.00
DML.TO cash_flow (annual, 2022-12-31) — End Cash Position: 50915000.00
DML.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 20959000.00
DML.TO balance_sheet (annual, 2022-12-31) — Finished Goods: 0.00
DML.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: -35013000.00
DML.TO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -21962000.00
DML.TO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 25000.00
DML.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: -25000.00
DML.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 45357000.00
DML.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 1782000.00
DML.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 12538000.00
DML.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 289050000.00
DML.TO income_statement (annual, 2022-12-31) — Gross Profit: 3820000.00
DML.TO balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 0.00
DML.TO cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 0.00
DML.TO income_statement (annual, 2022-12-31) — Interest Expense: 60000.00
DML.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 60000.00
DML.TO income_statement (annual, 2022-12-31) — Interest Income: 1419000.00
DML.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1419000.00
DML.TO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 6000.00
DML.TO balance_sheet (annual, 2022-12-31) — Inventory: 2713000.00
DML.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 436016000.00
DML.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -6761000.00
DML.TO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 87000.00
DML.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 181928000.00
DML.TO balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 19305000.00
DML.TO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 19551000.00
DML.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 158000.00
DML.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 158000.00
DML.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -209000.00
DML.TO balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 19305000.00
DML.TO balance_sheet (annual, 2022-12-31) — Long Term Provisions: 26594000.00
DML.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 108831000.00
DML.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -800000.00
DML.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 19551000.00
DML.TO cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -816000.00
DML.TO income_statement (annual, 2022-12-31) — Net Income: 14354000.00
DML.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 14354000.00
DML.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 12572000.00
DML.TO income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 1782000.00
DML.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 14354000.00
DML.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 12572000.00
DML.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 14354000.00
DML.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 14354000.00
DML.TO income_statement (annual, 2022-12-31) — Net Interest Income: -1415000.00
DML.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
DML.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 158000.00
DML.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 158000.00
DML.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -1415000.00
DML.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -209000.00
DML.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 896000.00
DML.TO balance_sheet (annual, 2022-12-31) — Net PPE: 253505000.00
DML.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -6857000.00
DML.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 436016000.00
DML.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 33330000.00
DML.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 28380000.00
DML.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 4950000.00
DML.TO balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1081000.00
DML.TO balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 0.00
DML.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: -26302000.00
DML.TO income_statement (annual, 2022-12-31) — Normalized Income: -20878482.80
DML.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: -28144000.00
DML.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -19866000.00
DML.TO income_statement (annual, 2022-12-31) — Operating Income: -36513000.00
DML.TO income_statement (annual, 2022-12-31) — Operating Revenue: 8973000.00
DML.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 826325592.00
DML.TO balance_sheet (annual, 2022-12-31) — Other Current Assets: 1367000.00
DML.TO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 336000.00
DML.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 1782000.00
DML.TO income_statement (annual, 2022-12-31) — Other Gand A: 12538000.00
DML.TO income_statement (annual, 2022-12-31) — Other Income Expense: 48231000.00
DML.TO balance_sheet (annual, 2022-12-31) — Other Investments: 162536000.00
DML.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: -11556000.00
DML.TO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 13203000.00
DML.TO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1441000.00
DML.TO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 5786000.00
DML.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 27795000.00
DML.TO balance_sheet (annual, 2022-12-31) — Other Payable: 829000.00
DML.TO balance_sheet (annual, 2022-12-31) — Other Receivables: 23000.00
DML.TO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 8022000.00
DML.TO balance_sheet (annual, 2022-12-31) — Payables: 10299000.00
DML.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 10299000.00
DML.TO balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 120000.00
DML.TO income_statement (annual, 2022-12-31) — Pretax Income: 10303000.00
DML.TO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 1459000.00
DML.TO cash_flow (annual, 2022-12-31) — Purchase Of Business: -800000.00
DML.TO cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
DML.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -6869000.00
DML.TO balance_sheet (annual, 2022-12-31) — Raw Materials: 2713000.00
DML.TO balance_sheet (annual, 2022-12-31) — Receivables: 4143000.00
DML.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 5153000.00
DML.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 8667000.00
DML.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -209000.00
DML.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: -1175256000.00
DML.TO cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
DML.TO cash_flow (annual, 2022-12-31) — Sale Of PPE: 12000.00
DML.TO income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 48000.00
DML.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 12538000.00
DML.TO balance_sheet (annual, 2022-12-31) — Share Issued: 826325592.00
DML.TO income_statement (annual, 2022-12-31) — Special Income Charges: -25000.00
DML.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 3736000.00
DML.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 436016000.00
DML.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 436016000.00
DML.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 11881517.20
DML.TO income_statement (annual, 2022-12-31) — Tax Provision: -2269000.00
DML.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
DML.TO balance_sheet (annual, 2022-12-31) — Taxes Receivable: 428000.00
DML.TO balance_sheet (annual, 2022-12-31) — Total Assets: 515796000.00
DML.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 436016000.00
DML.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 436016000.00
DML.TO income_statement (annual, 2022-12-31) — Total Expenses: 45486000.00
DML.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 79780000.00
DML.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 448636000.00
DML.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 61365000.00
DML.TO income_statement (annual, 2022-12-31) — Total Other Finance Cost: 2774000.00
DML.TO income_statement (annual, 2022-12-31) — Total Unusual Items: 45332000.00
DML.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 45332000.00
DML.TO cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: -22953000.00
DML.TO balance_sheet (annual, 2022-12-31) — Working Capital: 48745000.00
DML.TO income_statement (annual, 2023-12-31) — +Operating Expense: 50754000.00
DML.TO income_statement (annual, 2023-12-31) — +Total Revenue: 1855000.00
DML.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 5037000.00
DML.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 1913000.00
DML.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -39341000.00
DML.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 69823000.00
DML.TO balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 117000.00
DML.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 848023000.00
DML.TO income_statement (annual, 2023-12-31) — Basic EPS: 0.11
DML.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 50915000.00
DML.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -3234000.00
DML.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 1655024000.00
DML.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 131054000.00
DML.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 141454000.00
DML.TO balance_sheet (annual, 2023-12-31) — Cash Equivalents: 127368000.00
DML.TO balance_sheet (annual, 2023-12-31) — Cash Financial: 3686000.00
DML.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 111179000.00
DML.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -719000.00
DML.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -30667000.00
DML.TO cash_flow (annual, 2023-12-31) — Change In Inventory: -866000.00
DML.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 759000.00
DML.TO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -253000.00
DML.TO cash_flow (annual, 2023-12-31) — Change In Receivables: 2230000.00
DML.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: 1870000.00
DML.TO cash_flow (annual, 2023-12-31) — Changes In Cash: 79793000.00
DML.TO balance_sheet (annual, 2023-12-31) — Common Stock: 1655024000.00
DML.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 641784000.00
DML.TO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 107863000.00
DML.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 3710000.00
DML.TO balance_sheet (annual, 2023-12-31) — Current Assets: 148541000.00
DML.TO balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 4535000.00
DML.TO balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 4535000.00
DML.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 17946000.00
DML.TO balance_sheet (annual, 2023-12-31) — Current Provisions: 2256000.00
DML.TO cash_flow (annual, 2023-12-31) — Deferred Income Tax: -2343000.00
DML.TO cash_flow (annual, 2023-12-31) — Deferred Tax: -2343000.00
DML.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 9391000.00
DML.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 853969000.00
DML.TO income_statement (annual, 2023-12-31) — Diluted EPS: 0.10
DML.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 90375000.00
DML.TO balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 623000.00
DML.TO balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 4843000.00
DML.TO income_statement (annual, 2023-12-31) — EBIT: 87073000.00
DML.TO income_statement (annual, 2023-12-31) — EBITDA: 96464000.00
DML.TO income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -4400000.00
DML.TO cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 4400000.00
DML.TO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 346000.00
DML.TO cash_flow (annual, 2023-12-31) — End Cash Position: 131054000.00
DML.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 111179000.00
DML.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: -33901000.00
DML.TO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -1299000.00
DML.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 1299000.00
DML.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 134648000.00
DML.TO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 1818000.00
DML.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 13760000.00
DML.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 294287000.00
DML.TO income_statement (annual, 2023-12-31) — Gross Profit: -1855000.00
DML.TO balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 15565000.00
DML.TO cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 0.00
DML.TO income_statement (annual, 2023-12-31) — Interest Expense: 52000.00
DML.TO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 52000.00
DML.TO income_statement (annual, 2023-12-31) — Interest Income: 4189000.00
DML.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 4189000.00
DML.TO cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 4000.00
DML.TO balance_sheet (annual, 2023-12-31) — Inventory: 3580000.00
DML.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 641784000.00
DML.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -719000.00
DML.TO balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 15682000.00
DML.TO balance_sheet (annual, 2023-12-31) — Investments And Advances: 309787000.00
DML.TO balance_sheet (annual, 2023-12-31) — Investmentsin Joint Venturesat Cost: 17290000.00
DML.TO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 107863000.00
DML.TO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
DML.TO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
DML.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -218000.00
DML.TO balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 17290000.00
DML.TO balance_sheet (annual, 2023-12-31) — Long Term Provisions: 32642000.00
DML.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 113474000.00
DML.TO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -2385000.00
DML.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 107863000.00
DML.TO cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -321000.00
DML.TO income_statement (annual, 2023-12-31) — Net Income: 90375000.00
DML.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 90375000.00
DML.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 89364000.00
DML.TO income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: 1011000.00
DML.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 90375000.00
DML.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 89364000.00
DML.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 90375000.00
DML.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 90375000.00
DML.TO income_statement (annual, 2023-12-31) — Net Interest Income: 619000.00
DML.TO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 4901000.00
DML.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -218000.00
DML.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -218000.00
DML.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 619000.00
DML.TO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -218000.00
DML.TO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -126000.00
DML.TO balance_sheet (annual, 2023-12-31) — Net PPE: 254946000.00
DML.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -3109000.00
DML.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 641784000.00
DML.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 33030000.00
DML.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 30423000.00
DML.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 2607000.00
DML.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: -39483000.00
DML.TO income_statement (annual, 2023-12-31) — Normalized Income: 7795800.00
DML.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -30667000.00
DML.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: 2780000.00
DML.TO income_statement (annual, 2023-12-31) — Operating Income: -48899000.00
DML.TO income_statement (annual, 2023-12-31) — Operating Revenue: 1855000.00
DML.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 890970371.00
DML.TO balance_sheet (annual, 2023-12-31) — Other Current Assets: 1594000.00
DML.TO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 333000.00
DML.TO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 1818000.00
DML.TO income_statement (annual, 2023-12-31) — Other Gand A: 13760000.00
DML.TO income_statement (annual, 2023-12-31) — Other Income Expense: 135301000.00
DML.TO balance_sheet (annual, 2023-12-31) — Other Investments: 276815000.00
DML.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -1750000.00
DML.TO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 13329000.00
DML.TO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1201000.00
DML.TO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 3754000.00
DML.TO income_statement (annual, 2023-12-31) — Other Operating Expenses: 36994000.00
DML.TO balance_sheet (annual, 2023-12-31) — Other Payable: 942000.00
DML.TO balance_sheet (annual, 2023-12-31) — Other Receivables: 27000.00
DML.TO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 10400000.00
DML.TO balance_sheet (annual, 2023-12-31) — Payables: 10822000.00
DML.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 10822000.00
DML.TO income_statement (annual, 2023-12-31) — Pretax Income: 87021000.00
DML.TO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 3534000.00
DML.TO cash_flow (annual, 2023-12-31) — Purchase Of Business: -2385000.00
DML.TO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -15000000.00
DML.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -3234000.00
DML.TO balance_sheet (annual, 2023-12-31) — Raw Materials: 3580000.00
DML.TO balance_sheet (annual, 2023-12-31) — Receivables: 1913000.00
DML.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 3710000.00
DML.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 9391000.00
DML.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -218000.00
DML.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: -1084881000.00
DML.TO cash_flow (annual, 2023-12-31) — Sale Of Investment: 19901000.00
DML.TO cash_flow (annual, 2023-12-31) — Sale Of PPE: 125000.00
DML.TO income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 0.00
DML.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 13760000.00
DML.TO balance_sheet (annual, 2023-12-31) — Share Issued: 890970371.00
DML.TO income_statement (annual, 2023-12-31) — Special Income Charges: 1299000.00
DML.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 3746000.00
DML.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 641784000.00
DML.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 641784000.00
DML.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 54378800.00
DML.TO income_statement (annual, 2023-12-31) — Tax Provision: -2343000.00
DML.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.40
DML.TO balance_sheet (annual, 2023-12-31) — Taxes Receivable: 364000.00
DML.TO balance_sheet (annual, 2023-12-31) — Total Assets: 726603000.00
DML.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 641784000.00
DML.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 641784000.00
DML.TO income_statement (annual, 2023-12-31) — Total Expenses: 50754000.00
DML.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 84819000.00
DML.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 578062000.00
DML.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 66873000.00
DML.TO income_statement (annual, 2023-12-31) — Total Other Finance Cost: 3518000.00
DML.TO income_statement (annual, 2023-12-31) — Total Unusual Items: 135947000.00
DML.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 135947000.00
DML.TO cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -134736000.00
DML.TO balance_sheet (annual, 2023-12-31) — Working Capital: 130595000.00
DML.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 892468000.00
DML.TO income_statement (quarterly, 2024-09-30) — Basic EPS: -0.03
DML.TO cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
DML.TO cash_flow (quarterly, 2024-09-30) — Depletion: 2309000.00
DML.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 892468000.00
DML.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.03
DML.TO income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: 20000.00
DML.TO cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
DML.TO cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
DML.TO income_statement (quarterly, 2024-09-30) — Net Income Discontinuous Operations: 0.00
DML.TO cash_flow (quarterly, 2024-09-30) — Net Investment Purchase And Sale: 0.00
DML.TO balance_sheet (quarterly, 2024-09-30) — Other Properties: 2473000.00
DML.TO cash_flow (quarterly, 2024-09-30) — Sale Of Investment: 0.00
DML.TO income_statement (quarterly, 2024-09-30) — Special Income Charges: 20000.00
DML.TO income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: 776000.00
DML.TO income_statement (annual, 2024-12-31) — +Operating Expense: 67346000.00
DML.TO income_statement (annual, 2024-12-31) — +Total Revenue: 4023000.00
DML.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 13289000.00
DML.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 3075000.00
DML.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -43064000.00
DML.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 73311000.00
DML.TO balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 1755000.00
DML.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 892238000.00
DML.TO income_statement (annual, 2024-12-31) — Basic EPS: -0.10
DML.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 131054000.00
DML.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -7690000.00
DML.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 1665189000.00
DML.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 108518000.00